Correlation Between Terns Pharmaceuticals and PTC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Terns Pharmaceuticals and PTC Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and PTC Therapeutics.

Diversification Opportunities for Terns Pharmaceuticals and PTC Therapeutics

-0.8

Correlation Coefficient

Terns Pharmaceuticals  PTC Therapeutics

Pay attention - limited upside

The 3 months correlation between Terns and PTC is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and PTC Therapeutics go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and PTC Therapeutics

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the PTC Therapeutics. In addition to that, Terns Pharmaceuticals is 1.49 times more volatile than PTC Therapeutics. It trades about -0.25 of its total potential returns per unit of risk. PTC Therapeutics is currently generating about 0.14 per unit of volatility. If you would invest  4,523  in PTC Therapeutics on December 27, 2024 and sell it today you would earn a total of  1,008  from holding PTC Therapeutics or generate 22.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Terns Pharmaceuticals  vs.  PTC Therapeutics

Terns Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

PTC Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Terns Pharmaceuticals and PTC Therapeutics

The main advantage of trading using opposite Terns Pharmaceuticals and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.

The idea behind Terns Pharmaceuticals and PTC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.